A new book co-edited by Alfred M. Rankin Professor of Law Abbe R. Gluck ’00 examines the COVID-19 pandemic’s implications on health care law and beyond.
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.
In the PROTECT trial, teplizumab preserved β-cell function in newly diagnosed type 1 diabetes patients, slowing the decline of C-peptide levels, but key secondary endpoints, such as time in range and HbA1c, showed numerical trends without statistical significance.
A surge in requests from Israeli doctors to leave the occupied territories at any cost has been reported since the Knesset (the parliament) passed a bill late last month that would overhaul the judiciary and limit its powers.